Similar articles

• Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia.

  Wallukat G, Neichel D, Nissen E, Homuth V, Luft FC. Wallukat G, et al. Can J Physiol Pharmacol. 2003 Feb;81(2):79-83. doi: 10.1139/y02-160. Can J Physiol Pharmacol. 2003. PMID: 12710518
• The Role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia.

  Campbell N, LaMarca B, Cunningham MW Jr. Campbell N, et al. Curr Pharm Biotechnol. 2018;19(10):781-785. doi: 10.2174/1389201019666180925121254. Curr Pharm Biotechnol. 2018. PMID: 30255752 Free PMC article. Review.
• Stimulating autoantibodies against the angiotensin II type 1 receptor are not associated with preeclampsia in Mexican-Mestizo women.

  Leaños-Miranda A, Campos-Galicia I, Alvarez-Jiménez G, Isordia-Salas I, Rivera-Leaños R, Ulloa-Aguirre A. Leaños-Miranda A, et al. J Hypertens. 2010 Apr;28(4):834-41. doi: 10.1097/HJH.0b013e3283376cc6. J Hypertens. 2010. PMID: 20139770
• Activating auto-antibodies against the AT1 receptor in preeclampsia.

  Dechend R, Müller DN, Wallukat G, Homuth V, Krause M, Dudenhausen J, Luft FC. Dechend R, et al. Autoimmun Rev. 2005 Jan;4(1):61-5. doi: 10.1016/j.autrev.2004.07.002. Autoimmun Rev. 2005. PMID: 15652781 Review.
• Autoantibody against angiotensin AT1 receptor from preeclamptic patients enhances collagen-induced human platelet aggregation.

  Bai K, Wang K, Li X, Wang J, Zhang J, Song L, Wang J, Zhang S, Lau WB, Ma X, Liu H. Bai K, et al. Acta Biochim Biophys Sin (Shanghai). 2013 Sep;45(9):749-55. doi: 10.1093/abbs/gmt059. Epub 2013 May 16. Acta Biochim Biophys Sin (Shanghai). 2013. PMID: 23681235